IDEAYA Biosciences
T Ashraf is an accomplished professional with extensive experience in drug safety and pharmacovigilance. Currently serving as an Adjunct Professor at the University of the Pacific - Thomas J. Long School of Pharmacy since November 2021 and as Vice President of Drug Safety and Pharmacovigilance at IDEAYA Biosciences since February 2024, T Ashraf has previously held the position of Vice President at Astex Pharmaceuticals, where expertise in oncology and hematology contributed to the approval of INQOVI. T Ashraf's background includes serving as Global Head of Clinical Regulatory Strategies at Vertex Pharmaceuticals, as well as a Senior Medical Director at Medtronic, focusing on multiple therapeutic areas. With a Master's degree in Health Planning, Epidemiology and Administration from the University of Cincinnati and an MD from the University of Health Sciences, T Ashraf possesses a solid educational foundation to support a successful career in the pharmaceutical industry.
This person is not in any teams
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California